Edition:
United States

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

4.39USD
3:33pm EDT
Change (% chg)

$-0.01 (-0.23%)
Prev Close
$4.40
Open
$4.34
Day's High
$4.43
Day's Low
$4.34
Volume
7,396
Avg. Vol
15,787
52-wk High
$10.67
52-wk Low
$3.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.27 December 20 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1 37.20 37.20 37.20 --
Quarter Ending Sep-18 1 33.90 33.90 33.90 --
Year Ending Dec-18 1 143.50 143.50 143.50 194.70
Year Ending Dec-19 1 181.30 181.30 181.30 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.27 -0.27 -0.27 --
Quarter Ending Sep-18 1 -0.39 -0.39 -0.39 --
Year Ending Dec-18 1 -1.26 -1.26 -1.26 0.38
Year Ending Dec-19 1 0.05 0.05 0.05 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 32.78 38.91 6.13 18.70
Quarter Ending Sep-17 35.95 28.67 7.28 20.25
Quarter Ending Jun-17 36.86 40.88 4.02 10.91
Quarter Ending Mar-17 35.55 29.98 5.57 15.66
Quarter Ending Dec-16 40.10 13.57 26.53 66.15

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 37.20 37.20 37.20 -- --
Quarter Ending Sep-18 33.90 33.90 33.90 -- --
Year Ending Dec-18 143.50 143.50 145.81 148.51 194.70
Year Ending Dec-19 181.30 181.30 175.95 170.59 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings